Clinical Trials List
2019-11-01 - 2026-12-31
Phase III
Recruiting6
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 羅喬 Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 林柏翰 Division of General Internal Medicine
- MING-YANG WANG Division of General Surgery
- YEN-SHEN LU Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
- SUNG-HSIN KUO Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 蔡立威 Division of General Surgery
- Wei-Wu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林燕淑 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 許志堅 Division of Ophthalmology
- 邱仁輝 Division of General Surgery
- 賴亦貞 Division of Radiology
- Yi-Fang Tsai Division of General Surgery
- Chun-Yu Liu Division of General Internal Medicine
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- 郭懿萱 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 褚乃銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 巫承哲 Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- Fu Ouyang Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Fang-Ming Chen Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- 高捷妮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 何景良 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 廖國秀 Division of General Surgery
- 陳宇欽 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 于承平 Division of Others
- 黃子權 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
320 participants
